Protara Therapeutics (TARA) Preferred Shares Issued (2017 - 2020)
Protara Therapeutics (TARA) recorded quarterly Preferred Shares Issued of -$41.0 million in Q4 2020, down 200.0% quarter-over-quarter from $41.0 million in Q3 2020.
Protara Therapeutics (TARA) Preferred Shares Issued (2017 - 2020) Analysis & Trends
Protara Therapeutics' Preferred Shares Issued history runs 2 years deep, the most recent figure standing at -$41.0 million for Q4 2020.
- In Q4 2020, Preferred Shares Issued changed N/A year-over-year to -$41.0 million; the TTM figure through Dec 2020 stood at $25.3 million (changed N/A YoY), while the FY2020 annual figure was $25.3 million, changed N/A from the prior year.
- Preferred Shares Issued was -$41.0 million for Q4 2020 at Protara Therapeutics, down from $41.0 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $41.0 million in Q3 2020 to a low of -$41.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -40.97 Mn |
| Dec 31, 2020 | -40.97 Mn |
| Sep 30, 2020 | 40.97 Mn |
| Sep 30, 2020 | 40.97 Mn |
| Mar 31, 2020 | 25.32 Mn |
| Mar 31, 2020 | 25.32 Mn |
| Dec 31, 2017 | -13,000.00 |
| Dec 31, 2017 | -13,000.00 |